Biolase Technology has eliminated 20 positions and made additional cost-cutting measures across the organization to "better position the company for future profitability," the company announced.
In connection with the corporate restructuring activities came the departure of Brett L. Scott, chief financial officer. Scott's responsibilities will be taken on, for an interim period, by David Mulder, chairman and CEO, and Biolase's corporate controller.
The reduction in headcount, along with additional expense reduction activities, is expected to reduce corporate expenses by approximately $3 million on an annual basis, the company said.
Copyright © 2010 DrBicuspid.com
